Global Connected Drug Delivery Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast: 2018–2027
“Global Connected Drug Delivery Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global connected drug delivery devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. Global connected drug delivery devices market report has been segmented on the basis of product type, technology, end user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our researchers have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Connected drug delivery devices are machines used to deliver various medicinal agents in patient’s body to give medical treatment and monitor patients behaviour accordingly. These devices are used to minimize patient’s non-adherence regarding medicinal prescriptions and to offer better health service. Connected users has access to a specialist portal, through which they can manage their condition and get advice remotely from healthcare professionals.
Increasing demand for connected drug delivery devices across various end-use industries such as homecare and hospitals is a major factor expected to drive growth of the target market over the next few years. In addition, increasing scope of its application in healthcare sector is another factor expected to support revenue growth of the target market over the next few years. Increasing penetration of IoT enabled devices and Internet are another factors expected to drive growth of the global market.
However, higher cost of connected drug delivery devices is a major factor expected to hamper growth of the global connected drug delivery devices market to the certain extent. In addition, unawareness regarding various advance technologies and electronic devices among general population is another factor expected to hinder growth of the target market. Moreover, lack of security standards and risk associated to data loss are some additional factor factors expected to hamper growth of the global market over the forecast period.
North America is expected to dominate the global connected healthcare market and expected to continue its dominance over the forecast period. This can be attributed to well-developed healthcare sector and well developed internet infrastructure in countries in the region. In addition, high spending on healthcare and rising awareness regarding contrary effects of non-adherence to prescribed medication. Market in Europe is expected to witness substantial growth, owing to increasing cases of chronic diseases. In addition, high disposable income and willingness to pay more for advanced healthcare services are other key factors expected to propel growth of the target market. Markets in Asia Pacific, Latin America, and Middle East & Africa are expected to register at moderate growth over the forecast period.
Segmentation and Key Players Operating in Global Connected Drug Delivery Devices Market:
Segmentation by product type:
- Connected Sensors
- Connected Inhaler Sensors
- Connected Injection Sensors
- Integrated Connected Devices
- Integrated Inhalation Devices
- Integrated Injection Devices
Segmentation by technology:
- Near Field Communication (NFC)
- Other Technologies (Cellular, Low Power Wide Area Network)
Segmentation by end user:
- Healthcare Providers
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Propeller Health
- Proteus Digital Health, Inc.
- Adherium Limited
- West Pharmaceutical Services, Inc
- Sagentia (Science Group)
- Cohero Health, Inc.
- Teva Pharmaceuticals Europe BV (CareTRx)
- CeQur SA
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!